In the BioHarmony Drug Report Database

"Preview" Icon

Enoxacin

Penetrex (enoxacin) is a small molecule pharmaceutical. Enoxacin was first approved as Penetrex on 1991-12-31. It is used to treat escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections, and proteus infections amongst others in the USA. It is known to target V-type proton ATPase subunit B, brain isoform.

 

Trade Name

 

Penetrex
 

Common Name

 

enoxacin
 

ChEMBL ID

 

CHEMBL826
 

Indication

 

escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections, proteus infections, pseudomonas infections, staphylococcal infections, urinary tract infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Enoxacin structure rendering